Literature DB >> 11020467

Diminished rate of mouse peritoneal macrophage cholesterol efflux is not related to the degree of HDL glycation in diabetes mellitus.

M Passarelli1, A F Shimabukuro, S Catanozi, E R Nakandakare, J C Rocha, A J Carrilho, E C Quintão.   

Abstract

The efflux of (14)C-cholesterol from mouse peritoneal macrophages mediated by in vivo and in vitro glycation of intact HDL(3) and by HDL(3) apolipoproteins was investigated. Cholesterol-laden cells were incubated a long time with HDL(3) from control subjects (C), poorly controlled diabetes mellitus patients (D) and with HDL C submitted to in vitro glycation (G), as well as with all their respectively isolated apolipoproteins. A diminished cholesterol efflux rate occurred in incubations with intact HDL(3) D but not with intact HDL(3)G or with apoHDL(3)C, G or D. The specific binding of (125)I-HDL(3)G to the cell receptor, obtained upon incubation in the absence and in the presence of excess unlabelled HDL(3), was lower than the control. The role of apoE secretion by cholesterol-laden macrophages on cholesterol efflux was analyzed by incubating apoE knockout and control mice macrophages with HDL C or HDL G: a lower cholesterol efflux was observed from apoE knockout macrophages but glycation of HDL(3) did not influence this process either. The diminished capacity to remove cholesterol by the HDL drawn from diabetic subjects must be attributed to other modifications of the lipoproteins, except for non enzymatic glycation. Thus, events that impair the cell cholesterol removal in diabetes mellitus are multifaceted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11020467     DOI: 10.1016/s0009-8981(00)00336-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Diminished macrophage cholesterol removal rate by the altered HDL metabolism in the Nagase analbuminemic rat.

Authors:  Sergio Catanozi; Jussara C Rocha; Marisa Passarelli; Carlos H Mesquita; Vivian Y Suguiama; Maria L Guzzo; Antônio dos Santos Filho; Eder C R Quintão; Edna R Nakandakare
Journal:  Lipids       Date:  2006-07       Impact factor: 1.880

Review 2.  Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease.

Authors:  Kerry-Anne Rye
Journal:  Clin Exp Nephrol       Date:  2013-09-20       Impact factor: 2.801

3.  Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice.

Authors:  Jan Freark de Boer; Wijtske Annema; Marijke Schreurs; Jelske N van der Veen; Markus van der Giet; Niels Nijstad; Folkert Kuipers; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2011-12-18       Impact factor: 5.922

Review 4.  HDL and Reverse Cholesterol Transport.

Authors:  Mireille Ouimet; Tessa J Barrett; Edward A Fisher
Journal:  Circ Res       Date:  2019-05-10       Impact factor: 17.367

5.  Human FABP1 T94A variant enhances cholesterol uptake.

Authors:  Huan Huang; Avery L McIntosh; Kerstin K Landrock; Danilo Landrock; Stephen M Storey; Gregory G Martin; Shipra Gupta; Barbara P Atshaves; Ann B Kier; Friedhelm Schroeder
Journal:  Biochim Biophys Acta       Date:  2015-02-27

6.  Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment.

Authors:  R de Vries; M N Kerstens; W J Sluiter; A K Groen; A van Tol; R P F Dullaart
Journal:  Diabetologia       Date:  2005-05-05       Impact factor: 10.122

7.  Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.

Authors:  Bronwyn E Brown; Estelle Nobecourt; Jingmin Zeng; Alicia J Jenkins; Kerry-Anne Rye; Michael J Davies
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study.

Authors:  Wijtske Annema; Arne Dikkers; Jan Freark de Boer; Marleen M J van Greevenbroek; Carla J H van der Kallen; Casper G Schalkwijk; Coen D A Stehouwer; Robin P F Dullaart; Uwe J F Tietge
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.